Evidence map›Paper›PMID 29290468›Full record

ArticleCell2018

Stabilization of Reversed Replication Forks by Telomerase Drives Telomere Catastrophe.

Pol Margalef, Panagiotis Kotsantis, Valerie Borel, Roberto Bellelli, Stephanie Panier, Simon J Boulton

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Ubiquitin-conjugating Enzymes in Cancer.International journal of biological sciences · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Telomerase misbehaves after a breakup.Science (New York, N.Y.) · 2024
    Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pol MargalefThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Panagiotis KotsantisThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Valerie BorelThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Roberto BellelliThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Stephanie PanierThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Simon J BoultonThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address: simon.boulton@crick.ac.uk.
The Francis Crick Institute · GB

Funding

Cancer Research UK 11581Cancer Research UK FC0010048Medical Research CouncilWellcome Trust
6 · The paper itself

Abstract

Telomere maintenance critically depends on the distinct activities of telomerase, which adds telomeric repeats to solve the end replication problem, and RTEL1, which dismantles DNA secondary structures at telomeres to facilitate replisome progression. Here, we establish that reversed replication forks are a pathological substrate for telomerase and the source of telomere catastrophe in Rtel1

Indexed as

DNA ReplicationTelomere HomeostasisAnimalsCell LineCells, CulturedDNA HelicasesGlycoside HydrolasesMicePoly (ADP-Ribose) Polymerase-1RecQ HelicasesUbiquitin-Conjugating EnzymesDNA HelicasesGlycoside HydrolasesParp1 protein, mousepoly ADP-ribose glycohydrolasePoly (ADP-Ribose) Polymerase-1RecQ Helicasesregulator of telomere length protein, mouseUbe2n protein, mouseUbiquitin-Conjugating Enzymesgenome stabilityHoyeraal-Hreidarsson syndromePARP1RECQ1replication fork reversalRTEL1telomerasetelomeresZRANB3

Identifiers

PMID29290468
PMCPMC5786504
OpenAlexW2778772830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.